Y. T. Konttinen

About

Y. T. Konttinen is a leading researcher in rheumatology and connective tissue disorders, with a primary focus on the vascular pathology underlying systemic sclerosis (SSc). Their major contributions center on elucidating the mechanisms of vascular damage and impaired angiogenesis in SSc, a condition characterized by severe microvascular abnormalities. In their highly cited 2003 study (67 citations), Konttinen demonstrated that while vascular endothelial growth factor (VEGF) and its receptors are increased in SSc skin, their expression is imbalanced, failing to promote effective angiogenesis. This paradoxical finding—elevated VEGF but insufficient new vessel formation—was further explored in a companion 2003 paper (42 citations), which highlighted the lack of angiogenesis despite vascular injury. By comparing SSc to systemic lupus erythematosus, Raynaud’s phenomenon, and healthy controls, Konttinen provided critical insights into why SSc patients suffer from persistent tissue ischemia and fibrosis. Their work has had a lasting impact on understanding the failure of reparative angiogenesis in autoimmune diseases, influencing subsequent research into therapeutic strategies targeting VEGF pathways. Konttinen’s studies remain foundational for researchers investigating vascular dysfunction in scleroderma and related conditions.

Research Focus

Key Achievements

Top Papers

1. 1
   Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin.

   67 citations · 2003
2. 2
   Vascular damage and lack of angiogenesis in systemic sclerosis skin

   42 citations · 2003

Key Collaborators

Contact & Links